Huangui Xiong

Prof. Huangui Xiong

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2010 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
YZYan Zhou
Yan Zhou
HTHongmei Tang
Hongmei Tang
JLJianuo Liu
Jianuo Liu
JDJun Dong
Jun Dong
Huangui XiongHuangui Xiong
Huangui Xiong
J. Neurochem. (2011) 116, 406–414. Abstract In addition to its well-characterized effects in immune system, chemokine CC motif ligand 2 (CCL2, formerly known as monocyte chemoattractant protein-1) is believed to play an important role in brain physiological and pathological processes. It has been shown that CCL2 and its cognate receptor chemokine CC motif receptor 2 are constitutively expressed in several brain regions including the hippocampus, and the expression is up-regulated under pathological conditions. Whereas most investigations have so far focused on its involvement in CNS pathology, few studies have examined the effects of CCL2 on neuronal and synaptic physiology. In this study, we tested the effects of CCL2 on neuronal excitability and excitatory synaptic transmission in the CA1 region of rat hippocampal slices using whole-cell patch clamp techniques. Bath application of CCL2 depolarized membrane potential and increased spike firing in CA1 neuronal cells. Bath application of CCL2 also produced an increase of excitatory post-synaptic currents recorded in Schaffer-collateral fibers to CA1 synapses. Quantal analysis revealed that CCL2 increased the frequency of spontaneous excitatory post-synaptic current occurrence and mean quantal content. Taken together, our data indicate that CCL2 enhances neuronal excitability and synaptic transmission via pre-synaptic mechanisms. These results support the emerging concept that chemokines function as neuromodulators in the CNS.

17 October 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
YCYu Cai
Yu Cai
LYLu Yang
Lu Yang
GHGuoku Hu
Guoku Hu
XCXufeng Chen
Xufeng Chen
FNFang Niu
Fang Niu
SBShilpa Buch
Shilpa Buch
Our findings suggest that morphine dysregulates synaptic balance in the hippocampus, a key center for learning and memory, via a novel signaling pathway involving reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, and autophagy. We demonstrate in this study that exposure of morphine to hippocampal neurons leads to a reduction in excitatory synapse densities with a concomitant enhancement of inhibitory synapse densities via activation of the μ opioid receptor. Furthermore, these effects of morphine are mediated by up-regulation of intracellular ROS from NADPH oxidase, leading, in turn, to sequential induction of ER stress and autophagy. The detrimental effects of morphine on synaptic densities were shown to be reversed by platelet-derived growth factor (PDGF), a pleiotropic growth factor that has been implicated in neuroprotection. These results identify a novel cellular mechanism involved in morphine-mediated synaptic alterations with implications for therapeutic interventions by PDGF.

11 August 2004 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EAEric R. Anderson
Eric R. Anderson
HGHoward E. Gendelman
Howard E. Gendelman
Huangui XiongHuangui Xiong
Huangui Xiong
Memantine, a low-to-moderate-affinity NMDA receptor antagonist, can be used to treat cognitive impairment associated with Alzheimer's disease. However, its potential neuroprotective effects for human immunodeficiency virus type 1-associated (HIV-1-associated) dementia are less well appreciated. To this end we studied hippocampal synaptic function in a severe combined immunodeficient (SCID) mouse model of HIV-1 encephalitis (HIVE). Human monocyte-derived macrophages (MDMs) infected with HIV-1ADAwere injected stereotactically into the caudate and putamen of SCID mice, generating HIVE. These brain subregions are among those most affected in humans. Impaired synaptic transmission and long-term potentiation (LTP) were detected in the CA1 region of hippocampal brain slices of HIVE mice. Memantine-treated HIVE mice showed significant improvements in synaptic function during frequency facilitation tests and LTP induced by high-frequency stimulation when compared with untreated animals. Immunocytochemical measures of neuronal antigens mirrored the neuronal physiological tests. These results demonstrate that memantine attenuates hippocampal synaptic impairment in murine HIVE and provide a rationale for its use in infected humans who experience cognitive decline.

12 November 2002 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
Huangui XiongHuangui Xiong
Huangui Xiong
JBJeffery Boyle
Jeffery Boyle
MWMatthew Winkelbauer
Matthew Winkelbauer
SGSanthi Gorantla
Santhi Gorantla
JZJialin Zheng
Jialin Zheng
HGHoward E. Gendelman
Howard E. Gendelman

28 February 2018 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
EXEnquan Xu
Enquan Xu
JLJianuo Liu
Jianuo Liu
HLHan Liu
Han Liu
XWXiaobei Wang
Xiaobei Wang
Huangui XiongHuangui Xiong
Huangui Xiong

19 January 2012 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JLJana Liu
Jana Liu
CXC Xu
C Xu
LCL Chen
L Chen
PXP Xu
P Xu
Huangui XiongHuangui Xiong
Huangui Xiong
Inflammatory responses mediated by activated microglia play a pivotal role in the pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders. Studies on identification of specific targets to control microglia activation and resultant neurotoxic activity are imperative. Increasing evidence indicate that voltage-gated K+ (Kv) channels are involved in the regulation of microglia functionality. In this study, we investigated Kv1.3 channels in the regulation of neurotoxic activity mediated by HIV-1 glycoprotein 120 (gp120)-stimulated rat microglia. Our results showed treatment of microglia with gp120 increased the expression levels of Kv1.3 mRNA and protein. In parallel, whole-cell patch-clamp studies revealed that gp120 enhanced microglia Kv1.3 current, which was blocked by margatoxin, a Kv1.3 blocker. The association of gp120 enhancement of Kv1.3 current with microglia neurotoxicity was demonstrated by experimental results that blocking microglia Kv1.3 attenuated gp120-associated microglia production of neurotoxins and neurotoxicity. Knockdown of Kv1.3 gene by transfection of microglia with Kv1.3-siRNA abrogated gp120-associated microglia neurotoxic activity. Further investigation unraveled an involvement of p38 MAPK in gp120 enhancement of microglia Kv1.3 expression and resultant neurotoxic activity. These results suggest not only a role Kv1.3 may have in gp120-associated microglia neurotoxic activity, but also a potential target for the development of therapeutic strategies.